Market: NYQ |
Currency:
Address:
📈 Q Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$139.38
-
Upside/Downside from Analyst Target:
45.02%
-
Broker Call:
18
-
Dividend Minimum 3 Year Yield:
-
-
EPS Growth Range (1Y):
-
-
Net Income Growth Range (1Y):
-
-
Revenue Growth Range (1Y):
-
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for Q
No earnings history available for this symbol.
📰 Related News & Research
-
S&P 500 (+0.44%), Nasdaq (+0.54%), and Dow (+0.36%)
April 6, 2026
U.S. stocks rose modestly Monday, with the S&P 500 (+0.4...
-
The Place Holdings Limited Responds to SGX Queries on FY2023 Annual Report: Disclosure, Board Diversity, and Director Commitments
April 6, 2026
The Place Holdings Limited: Detailed Response to SGX Queries...
-
HC Surgical Specialists Acquires 51% of Chirurgia to Expand Minimally Invasive and HPB Surgery Services in Singapore
April 6, 2026
HC Surgical Specialists Acquires 51% Stake in Chirurgia Pte....
-
HC Surgical Specialists Limited Acquires 51% Stake in Chirurgia Pte. Ltd. to Expand Minimally Invasive Surgery Services in Singapore
April 6, 2026
HC Surgical Specialists Limited: Strategic Acquisition of Ch...
-
Anterix Inc. Announces New Contract and SEC Filing Details – Nasdaq Capital Market Listing and Company Information
April 6, 2026
Anterix Inc. Announces Milestone 900 MHz Spectrum Sale to No...
-
Neurocrine Biosciences Acquires Soleno Therapeutics for $2.9 Billion, Expands Rare Disease Portfolio With FDA-Approved VYKAT XR for Prader-Willi Syndrome 1
April 6, 2026
Neurocrine Biosciences to Acquire Soleno Therapeutics: In-De...
-
Neurocrine Biosciences to Acquire Soleno Therapeutics for $2.9 Billion, Expanding Rare Disease Portfolio with VYKAT XR for Prader-Willi Syndrome
April 6, 2026
Neurocrine to Acquire Soleno Therapeutics for \$2.9 Billion ...
-
Expand Energy Corporation Appoints Marcel Teunissen as Chief Financial Officer – NASDAQ EXE News April 2026 7
April 6, 2026
Expand Energy Corporation Appoints New CFO: Detailed Investo...
-
Strategy Inc (STRC) Reports 2026 Bitcoin Holdings, Financial Highlights, and Trading Information on NASDAQ
April 6, 2026
Strategy Inc. 8-K Report: Key Highlights for Investors (Apri...
-
Strive, Inc. (ASST) Files 8-K Disclosing Merger with Semler Scientific and Details on NASDAQ-Listed Common and Preferred Stock
April 6, 2026
Strive, Inc. Announces Key Treasury Holdings and Merger Upda...
🔍 View more Reports